Decorin induced by progesterone plays a crucial role in suppressing endometriosis

Journal of Endocrinology

Volumn 223, Issue 2, 2014, Pages 203-216

  Ono, Yoshihiro Joshua ^a   Terai, Yoshito ^a   Tanabe, Akiko ^a   Hayashi, Atsushi ^a   Hayashi, Masami ^a   Yamashita, Yoshiki ^a   Kyo, Satoru ^b   Ohmichi, Masahide ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cell cycle arrest; Decorin; Dienogest; Endometriosis; p21; Progesterone

Indexed keywords

DECORIN; DIENOGEST; MESSENGER RNA; PROGESTERONE; PROTEIN P21; DCN PROTEIN, HUMAN; NANDROLONE;

ADULT; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMORTALIZED CELL LINE; IN VITRO STUDY; PROTEIN INDUCTION; STROMA CELL; ANALOGS AND DERIVATIVES; CELL CULTURE; CELL CYCLE; CROSS-SECTIONAL STUDY; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; OVARIAN DISEASES; PHYSIOLOGY; RETROSPECTIVE STUDY; TRANSCRIPTION INITIATION; YOUNG ADULT;

ADULT; CELL CYCLE; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; DECORIN; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; NANDROLONE; OVARIAN DISEASES; PROGESTERONE; RETROSPECTIVE STUDIES; TRANSCRIPTIONAL ACTIVATION; YOUNG ADULT;

EID: 84915803873     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0393     Document Type: Article

References (53)

1. American Society for Reproductive Medicine 1997 Revised American Society for Reproductive Medicine classification of endometriosis. Fertility and Sterility 67 817-821. (doi:10.1016/S0015-0282(97)81391-X)
2. Bono Y, Kyo S, Takakura M, Maida Y, Mizumoto1 Y, Nakamura M, Nomura K, Kiyono T & Inoue M 2012 Creation of immortalised epithelial cells from ovarian endometrioma. British Journal of Cancer 106 1205-1213. (doi:10.1038/bjc.2012.26)
3. Brown J, Pan A & Hart RJ 2010 Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database of Systematic Reviews 12 CD008475. (doi:10.1002/14651858.CD008475. pub2)
4. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL et al. 2009 The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 55 611-622. (doi:10.1373/clinchem. 2008.112797)
5. Cawthorn TR, Moreno JC, Dharsee M, Tran-Thanh D, Ackloo S, Zhu PH, Sardana G, Chen J, Kupchak P, Jacks LM et al. 2012 Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. PLoS ONE 7 e30992. (doi:10.1371/journal.pone.0030992)
6. Cosson M, Querleu D, Donnez J, Madelenat P, Konincks P, Audebert A & Manhes H 2002 Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertility and Sterility 77 684-692. (doi:10.1016/S0015-0282(01)03270-8)
7. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE & Iozzo RV 1997 Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. Journal of Cell Biology 136 729-743. (doi:10.1083/jcb.136.3.729)
8. Eskenazi B & Warner ML 1997 Epidemiology of endometriosis. Obstetrics and Gynecology Clinics of North America 24 235-258. (doi:10.1016/ S0889-8545(05)70302-8)
9. Fairlie DP, West ML & Wong AK 1998 Towards protein surface mimetics. Current Medicinal Chemistry 5 29-62.
10. Felice P, Daniela H, Christian S, Thomas F, Christoph G, Stefano L, Lucia L & Thomas S 2012 Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Archives of Gynecology and Obstetrics 285 167-173. (doi:10.1007/s00404-011-1941-7)
11. Foster RH & Wilde MI 1998 Dienogest. Drugs 56 825-833. (doi:10.2165/ 00003495-199856050-00007)
12. Fu L, Osuga Y, Morimoto C, Hirata T, Hirota Y, Yano T & Taketani Y 2008 Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. Fertility and Sterility 89 1344-1347. (doi:10.1016/j.fertnstert.2007.03.042)
13. Giudice LC & Kao LC 2004 Endometriosis. Lancet 64 1789-1799. (doi:10.1016/S0140-6736(04)17403-5)
14. Goldoni S & Iozzo RV 2008 Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. International Journal of Cancer 123 2473-2479. (doi:10.1002/ijc.23930)
15. Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, Mc-Quillan DJ, Ireton K & Iozzo RV 2009 Decorin is a novel antagonistic ligand of the Met receptor. Journal of Cell Biology 185 743-754. (doi:10.1083/jcb. 200901129)
16. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M & Iozzo RV 2002 Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21 4765-4777. (doi:10.1038/sj.onc.1205595)
17. Guo SW 2009 Recurrence of endometriosis and its control. Human Reproduction Update 15 441-461. (doi:10.1093/humupd/dmp007)
18. Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T & Terakawa N 2005 Progesterone and progestational compounds attenuate tumor necrosis factor a-induced interleukin-8 production via nuclear factor k B inactivation in endometriotic stromal cells. Fertility and Sterility 83 1530-1535. (doi:10.1016/j.fertnstert.2004.11.042)
19. Iozzo RV 1997 The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Critical Reviews in Biochemistry and Molecular Biology 32 141-174. (doi:10.3109/ 10409239709108551)
20. Iozzo RV 1998 Matrix proteoglycans: from molecular design to cellular function. Annual Review of Biochemistry 67 609-652. (doi:10.1146/ annurev.biochem.67.1.609)
21. Iozzo RV & Sanderson RD 2011 Proteoglycans in cancer biology, tumor microenvironment and angiogenesis. Journal of Cellular and Molecular Medicine 15 1013-1031. (doi:10.1111/j.1582-4934.2010.01236.x)
22. Irahara M, Harada T, Momoeda M & Taketani Y 2007 Hormonal and histological study on irregular genital bleeding in patients with endometriosis during treatment with dienogest, a novel progestational therapeutic agent. Reproductive Medicine and Biology 6 223-228. (doi:10.1111/j.1447-0578.2007.00189.x)
23. Jee BC, Lee JY, Suh CS, Kim SH, Choi YM & Moon SY 2009 Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertility and Sterility 91 40-45. (doi:10.1016/j.fertnstert.2007.11.027)
24. Keene DR, San Antonio JD, Mayne R, McQuillan DJ, Sarris G, Santoro SA & Iozzo RV 2000 Decorin binds near the C terminus of type I collagen. Journal of Biological Chemistry 275 21801-21804. (doi:10.1074/ jbc.C000278200)
25. Köhler G, Faustmann TA, Gerlinger C, Seitz C & Mueck AO 2010 A doseranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. International Journal of Gynaecology and Obstetrics 108 21-25. (doi:10.1016/j.ijgo.2009.08.020)
26. Koninger J, Giese NA, Francescodi Mola F, Berberat P, Giese T, Esposito I, Bachem MG & Friess H 2004 Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action. Clinical Cancer Research 10 4776-4783. (doi:10.1158/1078-0432.CCR-1190-03)
27. Kresse H, Hausser H & Schönherr E 1993 Small proteoglycans. Experientia 49 403-416. (doi:10.1007/BF01923585)
28. Krikun G & Mor G 2004 A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 145 2291-2296. (doi:10.1210/en.2003-1606)
29. Lockwood CJ & Nemerson Y 1993 Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. Journal of Clinical Endocrinology and Metabolism 76 231-236. (doi:10.1210/jcem.76.1.8421090)
30. Momoeda M, Harada T, Terakawa N, Aso T, Fukunaga M, Hagino H & Taketani Y 2009 Long-term use of dienogest for the treatment of endometriosis. Journal of Obstetrics and Gynaecology Research 35 1069-1076. (doi:10.1111/j.1447-0756.2009.01076.x)
31. Nap AW, Griffioen AW, Dunselman GA, Bouma-ter Steege JC, Thijssen VL, Evers JL & Groothuis PG 2004 Antiangiogenesis therapy for endometriosis. Journal of Clinical Endocrinology and Metabolism 89 1089-1095. (doi:10.1210/jc.2003-031406)
32. Nash MA, Loercher AE & Freedman RS 1999 In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. Cancer Research 59 6192-6196.
33. Neame PJ & Kay CJ 2000 Small leucine-rich proteoglycans. In Proteoglycans, Structure, Biology and Molecular Interactions, pp 201-235. Ed. RV Iozzo. New York, NY: Marcel Dekker, Inc.
34. Okada H, Nakajima T, Yoshimura T, Yasuda K & Kanzaki H 2001 The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Molecular Human Reproduction 7 341-347. (doi:10.1093/molehr/7.4.341)
35. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, McQuillan DJ & Izzo RV 2005 Decorin prevents metastatic spreading of breast cancer. Oncogene 24 1104-1110. (doi:10.1038/sj.onc.1208329)
36. Salgado RM, Favaro RR & Zorn TM 2011 Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone. Reproductive Biology and Endocrinology 9 22. (doi:10.1186/ 1477-7827-9-22)
37. Santra M, Danielson KG & Iozzo RV 1994 Structural and functional characterization of the human decorin gene promoter. Journal of Biological Chemistry 269 579-587.
38. Santra M, Skorski T, Calabretta B, Lattime EC & Iozzo RV 1995 De novo decorin gene expression suppresses themalignant phenotype in human colon cancer cells. PNAS 92 7016-7020. (doi:10.1073/pnas.92.15.7016)
39. Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S & Mizuguchi K 2008 Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 73 222-231. (doi:10.1016/j.steroids.2007.10.003)
40. Schaefer L, Tsalastra W, Babelova A, Baliova M, Minnerup J, Sorokin L, Grone HJ, Reinhardt DP, Pfeilschifter J, Iozzo RV et al. 2007 Decorinmediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and mammalian target of rapamycin. American Journal of Pathology 170 301-315. (doi:10.2353/ajpath.2007.060497)
41. Seidler DG & Dreier R 2008 Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function? IUBMB Life 60 729-733. (doi:10.1002/iub.115)
42. Shimizu Y, Takeuchi T, Mita S, Mizuguchi K, Kiyono T, Inoue M & Kyo S 2009 Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression. Molecular Human Reproduction 15 693-701. (doi:10.1093/molehr/gap042)
43. Sitruk WR 2004a New progestogens: a review of their effects in perimenopausal and postmenopausal women. Drugs & Aging 21 865-883. (doi:10.2165/00002512-200421130-00004)
44. Sitruk WR 2004b Pharmacological profile of progestins. Maturitas 47 277-283. (doi:10.1016/j.maturitas.2004.01.001)
45. Strowitzki T, Faustmann A, Christoph G & Seitz C 2010a Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 151 193-198. (doi:10.1016/j.ejogrb.2010.04.002)
46. Strowitzki T, Marr J, Gerlinger C, Faustmann T & Seitz C 2010b Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Human Reproduction 25 633-641. (doi:10.1093/ humrep/dep469)
47. Su AI,Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G et al. 2004 A gene atlas of the mouse and human protein-encoding transcriptomes. PNAS 101 6062-6067. (doi:10.1073/pnas.0400782101)
48. Thomas N & Liliana S 2012 A guardian from the matrix. American Journal of Pathology 181 380-387. (doi:10.1016/j.ajpath.2012.04.029)
49. Vercellini P, Somigliana E, Viganò P, Abbiati A, Barbara G & Crosignani PG 2009 Endometriosis: current therapies and new pharmacological developments. Drugs 69 649-675. (doi:10.2165/00003495-200969060-00002)
50. Weber IT, Harrison RW & Iozzo RV 1996 Model structure of decorin and implications for collagen fibrillogenesis. Journal of Biological Chemistry 271 31767-31770. (doi:10.1074/jbc.271.50.31767)
51. Zhang YW, Su Y, Volpert OV & Vande Woude GF 2003 Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. PNAS 100 12718-12723. (doi:10.1073/pnas.2135113100)
52. Zhang G, Ezura Y, Chervoneva I, Robinson PS, Beason DP, Carine ET, Soslowsky LJ, Iozzo RV & Birk DE 2006 Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development. Journal of Cellular Biochemistry 98 1436-1449. (doi:10.1002/jcb.20776)
53. Zhang G, Chen S, Goldoni S, Calder BW, Simpson HC, Owens RT, McQuillan DJ, Young MF, Iozzo RV & Birk DE 2009 Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. Journal of Biological Chemistry 284 8888-8897. (doi:10.1074/jbc.M806590200)